ASML reports its order book is fully booked through 2028 amid split investor sentiment.

ASML’s production capacity for both EUV and immersion systems is effectively booked through the end of 2028, with the company pledging to expand 2027 capacity by approximately 30 percent. Such strong demand visibility would typically resolve any valuation debate, yet it has not. Second-quarter regulatory filings reveal a sharp divergence among institutional shareholders, with several of the world’s largest asset managers executing opposing trades simultaneously.

On the buying side, Dan Loeb’s Third Point increased its position by 150 percent, raising its stake from 12,000 to 30,000 shares. Caitong International Asset Management expanded its holding by a remarkable 611.1 percent. Mitsubishi UFJ, Greenwoods Asset Management of Hong Kong, BlackRock, T. Rowe Price, and Fisher Asset Management—all of which already held significant positions, including Fisher’s 4.4 million shares—also added to their holdings, with Fisher increasing its stake by an additional 3 percent.

Sellers, meanwhile, tell a contrasting story. Deutsche Bank reduced its ASML position by 44 percent during the quarter, Deepwater Asset Management slashed its stake by 72.3 percent, and Coatue Management trimmed 41 percent. This turnover indicates that following a fierce twelve-month rally, the debate over ASML’s valuation has grown genuinely contentious—even as the company’s operational outlook has rarely appeared stronger.

This shareholder tension mirrors a deeper strategic challenge within ASML’s product portfolio. Its High-NA EUV systems constitute a genuine technological monopoly, representing the most expensive and complex lithography machines ever constructed, priced between $350 million and $410 million apiece. Yet potential buyers are showing little urgency. Should investors sell immediately, or is it worth accumulating ASML Holding at current levels?

Intel has emerged as the first chipmaker to deploy High-NA in high-volume manufacturing, utilizing the systems for select layers of its “Panther Lake” processors built on the 18A node—a clear demonstration that the technology is production-ready. TSMC, however, has indicated it will not adopt High-NA for mass production until at least 2029, citing prohibitive costs. Samsung is taking an even more cautious stance: Technology Vice President ChangMin Park stated the company will not begin High-NA mass production until its 1-nanometer A10 node around 2030, arguing the technology lacks sufficient maturity for its current 2-nanometer and 1.4-nanometer processes.

These delays primarily affect ASML’s newest and most expensive generation. Existing EUV and immersion production lines remain fully utilized, which is precisely why ASML can confidently secure orders through 2028. The company’s pricing power on its core equipment remains intact, even as its flagship innovation awaits broader market readiness.

Compounding these dynamics is a persistent geopolitical overhang. The proposed U.S. MATCH Act could compel ASML to halt shipments of older DUV systems to China—and, more significantly, cease servicing machines already deployed there. This service-restriction clause transforms a prospective China-related risk into an immediate operational concern, a regulatory threat that robust order-book visibility cannot offset.

Market pricing has reflected this caution. The stock closed Thursday at €1,500.60, down 5.6 percent over seven trading days and roughly 5 percent over the past month. It currently trades 14 percent below its 52-week high of €1,748.00. Nevertheless, the longer-term trajectory remains strongly positive: shares have gained 63 percent year-to-date, 137 percent over the trailing twelve months, and 146 percent from the September 2 low of last year. Recent weakness appears more indicative of a consolidation phase following an exceptional run than a fundamental reversal.

Wall Street Zen captured this evolving sentiment on Tuesday, downgrading the stock from “Buy” to “Hold”—a measured but symbolic signal that initial euphoria has moderated. Concurrently, a state-backed manufacturer in Shanghai has commenced series production of its own immersion DUV lithography systems, albeit at minimal scale: five units scheduled for 2026 and twenty for 2027, targeting domestic clients such as SMIC and CXMT. This development serves as a reminder that while ASML’s competitive moat remains formidable, it is not entirely impregnable.

The next pivotal catalyst arrives on October 14, when ASML releases third-quarter earnings. With capacity locked through 2028, investor attention will pivot to execution: specifically, how the company manages its planned 30 percent capacity expansion for 2027 and whether it can maintain pricing discipline as major clients delay adoption of its most advanced tools.

For now, ASML stands as a study in contrasts: an order book extending years into the future, a technological advantage unmatched by rivals, and an institutional investor base divided on whether those factors justify accumulation or distribution. Ultimately, the resolution may hinge less on ASML’s manufacturing capabilities than on Washington’s export policies and customer willingness to absorb premium pricing.

ASML Holding Stock: New Analysis – 21 August. Fresh data and market developments have recently emerged regarding ASML Holding. Our latest independent report evaluates these figures and prevailing trends to assess potential investor impact. Read our updated ASML Holding analysis.